BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22321275)

  • 1. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
    Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
    Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
    Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
    Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
    J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
    Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
    Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance in cardiac amyloidosis.
    Maceira AM; Joshi J; Prasad SK; Moon JC; Perugini E; Harding I; Sheppard MN; Poole-Wilson PA; Hawkins PN; Pennell DJ
    Circulation; 2005 Jan; 111(2):186-93. PubMed ID: 15630027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and cardiac imaging features of patients with cardiac amyloidosis].
    Zhao L; Tian Z; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):960-4. PubMed ID: 26888807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
    Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of clinical and imaging features of cardiac amyloidosis: a multicenter study].
    Zhang L; Tang H; Chen L; Wu X; Cheng L; Wang Z; Wang Y; Huang H; Li J; Wang J; Feng B; Zhi G
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):295-302. PubMed ID: 24670437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.
    Kwong RY; Heydari B; Abbasi S; Steel K; Al-Mallah M; Wu H; Falk RH
    Am J Cardiol; 2015 Aug; 116(4):622-9. PubMed ID: 26076990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.
    Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A
    Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
    Cui Q; Yu J; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac amyloidosis: in search of the ideal diagnostic tool.
    Mavrogeni SI; Vartela V; Ntalianis A; Vretou R; Ikonomidis I; Tselegkidou M; Paraskevaidis I; Markousis-Mavrogenis G; Noutsias M; Rigopoulos A; Kolovou G; Kastritis E
    Herz; 2021 Apr; 46(Suppl 1):9-14. PubMed ID: 31796976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
    Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
    Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
    J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
    Cheng AS; Banning AP; Mitchell AR; Neubauer S; Selvanayagam JB
    Int J Cardiol; 2006 Oct; 113(1):E21-3. PubMed ID: 17049635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.